11:52 AM EST - Nuvo Research Inc. : announced the U. S. launch of Synera® (70 mg lidocaine/ 70 mg tetracaine/ heated topical patch). Synera is approved by the U.S. Food and Drug Administration (FDA) for use on intact skin to provide local dermal analgesia for superficial venous access and superficial dermatological procedures such as excision, electrodessication and shave biopsy of skin lesions. Nuvo Research Inc.
shares T.NRI are trading up $0.005 at $0.06.
